EMV emvision medical devices ltd

EMVision Medical Devices ’s PostEMVision Medical Devices3,788...

  1. 13,822 Posts.
    lightbulb Created with Sketch. 2938

    EMVision Medical Devices ’s Post

    View organization page for EMVision Medical Devices

    3,788 followers

    2h

    We are pleased to announce that we have commenced the pivotal trial, designed to support FDA De Novo clearance, for our first commercial device, the emu™ bedside brain scanner.The Royal Melbourne Hospital has been greenlit to commence as the first Australian hospital after a successful site initiation visit and with operator training in process. The Royal Melbourne Hospital is a world-class comprehensive stroke centre, and home to the Melbourne Brain Centre - the largest brain research collaboration in the southern hemisphere. We are proud to continue our close collaboration with the team at The Royal Melbourne Hospital, who were instrumental to the success of our prior pre-validation 'EMView' study.In addition, an emu™ device has been shipped to our first US site, University of Texas Health Science Center at Houston (UTHealth) Medical School and Memorial Hermann-Texas Medical Center (TMC). UTHealth Houston has a long tradition of stroke care innovation, having pioneered the use of tissue-type plasminogen activator (tPA), a life saving treatment for acute ischaemic stroke, and mobile stroke units to expedite its delivery. A site initiation visit is planned for the coming weeks.Additional sites will be announced and activated shortly.Read more here https://lnkd.in/g8N4Na8X

    • No alternative text description for this image
    Dr. Thomas J., graphic
    Dr. Thomas J.

    Thomas Jreige | Risk Management | Global Security, Geopolitics & Digital Counter-Terrorism Expert | Strategic CIO/CISO/CSO & International Relations | BSc, MSc, LLB, LLM, MBA, PhD (Strategic Studies), DipPsych

    1h

    Huge congratulations to the entire team on reaching this incredible milestone!The emu™ bedside brain scanner represents the kind of innovation that has real-world, life-saving impact—and it’s exciting to see such a strong collaboration between world-class centres like The Royal Melbourne Hospital and UTHealth Houston.Pivotal trials are a major step forward, not just for regulatory pathways, but for transforming stroke care at the bedside. Looking forward to watching this journey unfold and seeing the difference this technology will make for patients and clinicians alike.

    Robert Droppa, graphic
    Robert Droppa

    General Manager, Government and Healthcare Solutions

    43m

    Exciting news!


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.80
Change
0.010(0.56%)
Mkt cap ! $153.9M
Open High Low Value Volume
$1.82 $1.85 $1.80 $78.92K 43.10K

Buyers (Bids)

No. Vol. Price($)
1 608 $1.80
 

Sellers (Offers)

Price($) Vol. No.
$1.85 2250 2
View Market Depth
Last trade - 13.42pm 16/06/2025 (20 minute delay) ?
EMV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.